Cited by 3,163Cancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancerCell death mechanisms and regulation

The DOI matches its Crossref record; 231 of the 232 references it cites were found in a registry or an index.

Blinded by the Light: The Growing Complexity of p53

Open access

Vousden, Karen H., Prives, Carol·2009·Cell

DOI 10.1016/j.cell.2009.04.037

Open this paper in CoChat — free account Open PDF

Abstract

While the tumor suppressor functions of p53 have long been recognized, the contribution of p53 to numerous other aspects of disease and normal life is only now being appreciated. This burgeoning range of responses to p53 is reflected by an increasing variety of mechanisms through which p53 can function, although the ability to activate transcription remains key to p53's modus operandi. Control of p53's transcriptional activity is crucial for determining which p53 response is activated, a decision we must understand if we are to exploit efficiently the next generation of drugs that selectively activate or inhibit p53.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2009.04.037

Cites

231 of 231 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

RETRACTED: hnRNP K: An HDM2 Target and Transcriptional Coactivator of p53 in Response to DNA Damage
Moumen, A., Masterson, P., O'Connor, M. J., & Jackson, S. P. (2005) · Cell · doi:10.1016/j.cell.2005.09.032 · Cited by 350
Retracted
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
p53 in health and disease
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,351
Self-citation
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019
Self-citation
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Chang, T.-C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C. J., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.010 · Cited by 2,010
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921

Flagged first, then by citations

Show all 232 references

1 of the 232 references couldn’t be matched to a known paper.

Sorted by citations

Items 901–1,000 of 1,016

P53 activation inhibits all types of hematopoietic progenitors and all stages of megakaryopoiesis
Mahfoudhi, E., Lordier, L., Marty, C., Pan, J., Roy, A., Roy, L., Rameau, P., Abbes, S., Debili, N., Raslova, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7881 · Cited by 53
Fine-tuning p53 activity through C-terminal modification significantly contributes to HSC homeostasis and mouse radiosensitivity
Wang, Y. V., Leblanc, M., Fox, N., Mao, J.-H., Tinkum, K. L., Krummel, K., Engle, D., Piwnica-Worms, D., Piwnica-Worms, H., Balmain, A., et al. (2011) · Genes & Development · doi:10.1101/gad.2024411 · Cited by 53
lncRNA TUG1 as a ceRNA promotes PM exposure-induced airway hyper-reactivity
Li, B., Huang, N., Wei, S., Xv, J., Meng, Q., Aschner, M., Li, X., & Chen, R. (2021) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.125878 · Cited by 53
Alkaloids and Colon Cancer: Molecular Mechanisms and Therapeutic Implications for Cell Cycle Arrest
Khan, H. Z., Alam, W., Alsharif, K. F., Aschner, M., Pervez, S., & Saso, L. (2022) · Molecules · doi:10.3390/molecules27030920 · Cited by 53
Base editing of the HBG promoter induces potent fetal hemoglobin expression with no detectable off-target mutations in human HSCs
Han, W., Qiu, H.-Y., Sun, S., Fu, Z.-C., Wang, G., Qian, X., Wang, L., Zhai, X., Jia, W. P., Wang, Y., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.10.007 · Cited by 53
The Apoptotic Function Analysis of p53, Apaf1, Caspase3 and Caspase7 during the Spermatogenesis of the Chinese Fire-Bellied Newt Cynops orientalis
Wang, D., Hu, J.-R., Wang, L., Hu, Y.-J., Tan, F.-Q., Zhou, H., Shao, J., & Yang, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039920 · Cited by 53
Cytotoxic effect of efavirenz is selective against cancer cells and associated with the cannabinoid system
Hecht, M., Harrer, T., Büttner, M., Schwegler, M., Erber, S., Fietkau, R., & Distel, L. V. (2013) · AIDS · doi:10.1097/qad.0b013e3283625444 · Cited by 53
Tumor suppression in skin and other tissues via cross-talk between vitamin D- and p53-signaling
Reichrath, J., Reichrath, S., Heyne, K., VOGT, T. M., & Roemer, K. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00166 · Cited by 53
Nucleoporin Nup155 is part of the p53 network in liver cancer
Hölzer, K., Ori‬‬, A., Cooke, A. M., Dauch, D., Drucker, E., Riemenschneider, P., Andrés‐Pons, A., DiGuilio, A. L., Mackmull, M., Baßler, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10133-z · Cited by 53
Tau affects P53 function and cell fate during the DNA damage response
Sola, M., Magrin, C., Pedrioli, G., Pinton, S., Salvadè, A., Papin, S., & Paganetti, P. (2020) · Communications Biology · doi:10.1038/s42003-020-0975-4 · Cited by 53
The different radiation response and radiation-induced bystander effects in colorectal carcinoma cells differing in p53 status
Wideł, M., Lalik, A., Krzywon, A., Poleszczuk, J., Fujarewicz, K., & Rzeszowska‐Wolny, J. (2015) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2015.06.003 · Cited by 53
Electrocatalysis in proteins, nucleic acids and carbohydrates
Paleček, E., Bartošík, M., Ostatná, V., & Trefulka, M. (2012) · The Chemical Record · doi:10.1002/tcr.201100029 · Cited by 52
The Tumor Suppressor, p53, Contributes to Radiosensitivity of Lung Cancer Cells by Regulating Autophagy and Apoptosis
Cheng, G., Kong, D., Hou, X., Liang, B., He, M., Liang, N., Ma, S., & Liu, X. (2012) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2012.1297 · Cited by 52
Regulation of Protein Quality Control by UBE4B and LSD1 through p53-Mediated Transcription
Periz, G., Lu, J., Zhang, T., Kankel, M. W., Jablonski, A. M., Kalb, R. G., McCampbell, A., & Wang, J. (2015) · PLoS Biology · doi:10.1371/journal.pbio.1002114 · Cited by 52
Mutation spectrum of TP53 gene predicts clinicopathological features and survival of gastric cancer
Tahara, T., Shibata, T., Okamoto, Y., Yamazaki, J., Kawamura, T., Horiguchi, N., Okubo, M., Nakano, N., Ishizuka, T., Nagasaka, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9770 · Cited by 52
Li–Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53
Zhou, R., Xu, A., Gingold, J. A., Strong, L. C., Zhao, R., & Lee, D. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.07.004 · Cited by 52
CDK16 Phosphorylates and Degrades p53 to Promote Radioresistance and Predicts Prognosis in Lung Cancer
Xie, J., Li, Y., Jiang, K., Hu, K., Zhang, S., Dong, X., Dai, X., Liu, L., Zhang, T., Yang, K., et al. (2017) · Theranostics · doi:10.7150/thno.21963 · Cited by 52
Wnt/β-catenin activation cooperates with loss of p53 to cause adrenocortical carcinoma in mice
Borges, K. S., Pignatti, E., Leng, S., Kariyawasam, D., Ruiz‐Babot, G., Ramalho, F. S., Taketo, M. M., Carlone, D. L., & Breault, D. T. (2020) · Oncogene · doi:10.1038/s41388-020-1358-5 · Cited by 52
Regulation of ferroptosis by non‑coding RNAs in the development and treatment of cancer (Review)
Luo, Y., Huang, Q., He, B., Liu, Y., Huang, S., & Xiao, J. (2020) · Oncology Reports · doi:10.3892/or.2020.7836 · Cited by 52
Antitumor Effects of PRIMA-1 and PRIMA-1Met (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?
Menichini, P., Monti, P., Speciale, A., Cutrona, G., Matis, S., Fais, F., Taìana, E., Neri, A., Bomben, R., Gentile, M., et al. (2021) · Cells · doi:10.3390/cells10010098 · Cited by 52
Tumor Cells and Cancer-Associated Fibroblasts: An Updated Metabolic Perspective
Gentric, G., & Mechta‐Grigoriou, F. (2021) · Cancers · doi:10.3390/cancers13030399 · Cited by 52
VRK1 interacts with p53 forming a basal complex that is activated by UV‐induced DNA damage
López-Sánchez, I., Valbuena, A., Vázquez-Cedeira, M., Khadake, J., Sanz-García, M., Carrillo-Jiménez, A., & Lazo, P. A. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.01.040 · Cited by 52
Extracellular Adenosine Sensing—A Metabolic Cell Death Priming Mechanism Downstream of p53
Long, J. S., Crighton, D., O’Prey, J., Mackay, G., Zheng, L., Palmer, T. M., Gottlieb, E., & Ryan, K. M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.03.016 · Cited by 52
Emerging role of tumor suppressor p53 in acute and chronic kidney diseases
Overstreet, J. M., Gifford, C. C., Tang, J., Higgins, P. J., & Samarakoon, R. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04505-w · Cited by 51
Saikosaponin-D Enhances Radiosensitivity of Hepatoma Cells under Hypoxic Conditions by Inhibiting Hypoxia-Inducible Factor-1a
Wang, B., Wang, X.-J., Kang, H., Bai, M., Guan, H., Wang, Z.-W., Zan, Y., Song, L., Min, W., Lin, S., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356648 · Cited by 51
Antitumor Activity and Induction of TP53-Dependent Apoptosis toward Ovarian Clear Cell Adenocarcinoma by the Dual PI3K/mTOR Inhibitor DS-7423
Kashiyama, T., Oda, K., Ikeda, Y., Shiose, Y., Hirota, Y., Inaba, K., Makii, C., Kurikawa, R., Miyasaka, A., Koso, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087220 · Cited by 51
MDM2 Inhibitor Nutlin-3a Induces Apoptosis and Senescence in Cutaneous T-Cell Lymphoma: Role of p53
Manfé, V., Biskup, E., Johansen, P., Kamstrup, M. R., Krejsgaard, T., Morling, N., Wulf, H. C., & Gniadecki, R. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.10 · Cited by 51
Sequence-dependent cooperative binding of p53 to DNA targets and its relationship to the structural properties of the DNA targets
Beno, I., Rosenthal, K., Levitine, M., Shaulov, L., & Haran, T. E. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq1044 · Cited by 51
MicroRNAs and the Warburg Effect: New Players in an Old Arena
Gao, P., Sun, L., He, X., Cao, Y., & Zhang, H. (2012) · Current Gene Therapy · doi:10.2174/156652312802083620 · Cited by 51
Oncogenic Functions of Secreted Frizzled-Related Protein 2 in Human Renal Cancer
Yamamura, S., Kawakami, K., Hirata, H., Ueno, K., Saini, S., Majid, S., & Dahiya, R. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0012 · Cited by 51
DNA-damage response in hematopoietic stem cells: an evolutionary trade-off between blood regeneration and leukemia suppression
Biechonski, S., Yassin, M., & Milyavsky, M. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx002 · Cited by 54
The Inhibitory Effect of Ginger Extract on Ovarian Cancer Cell Line; Application of Systems Biology
Pashaei‐Asl, R., Pashaei-Asl, F., Gharabaghi, P. M., Khodadadi, K., Ebrahimi, M., Ebrahimie, E., & Pashaiasl, M. (2017) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2017.029 · Cited by 51
Proteasome dysregulation in human cancer: implications for clinical therapies
Chen, Y., Zhang, Y., & Guo, X. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9704-y · Cited by 51
Targeting p53-dependent stem cell loss for intestinal chemoprotection
Leibowitz, B. J., Yang, L., Liang, W., Buchanan, M. E., Rachid, M., Parise, R. A., Beumer, J. H., Eiseman, J. L., Schoen, R. E., Zhang, L., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aam7610 · Cited by 51
Concomitant TP53 mutations with response to crizotinib treatment in patients with ALK‐rearranged non‐small‐cell lung cancer
Song, P., Zhang, F., Li, Y., Yang, G., Li, W., Ying, J., & Gao, S. (2019) · Cancer Medicine · doi:10.1002/cam4.2043 · Cited by 51
Feedback Control of p53 Translation by REDD1 and mTORC1 Limits the p53-Dependent DNA Damage Response
Vadysirisack, D. D., Baenke, F., Ory, B., Lei, K., & Ellisen, L. W. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05541-11 · Cited by 51
Double-Edged Swords as Cancer Therapeutics: Novel, Orally Active, Small Molecules Simultaneously Inhibit p53–MDM2 Interaction and the NF-κB Pathway
Zhuang, C., Miao, Z., Wu, Y., Guo, Z., Li, J., Yao, J., Xing, C., Sheng, C., & Zhang, W. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401800k · Cited by 50
The mTOR pathway negatively controls ATM by up-regulating miRNAs
Shen, C., & Houghton, P. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220898110 · Cited by 50
A Small-Molecule p53 Activator Induces Apoptosis through Inhibiting MDMX Expression in Breast Cancer Cells
Wang, H., & Yan, C. (2011) · Neoplasia · doi:10.1593/neo.11438 · Cited by 50
Autophosphorylation and Pin1 binding coordinate DNA damage-induced HIPK2 activation and cell death
Bitomsky, N., Conrad, E., Moritz, C., Polonio-Vallon, T., Sombroek, D., Schultheiss, K., Glas, C., Greiner, V., Herbel, C., Mantovani, F., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310001110 · Cited by 50
S-phase sensing of DNA-protein crosslinks triggers TopBP1-independent ATR activation and p53-mediated cell death by formaldehyde
Wong, V. C., Cash, H. L., Morse, J., Lü, S., & Zhitkovich, A. (2012) · Cell Cycle · doi:10.4161/cc.20905 · Cited by 50
Dux4 induces cell cycle arrest at G1 phase through upregulation of p21 expression
Xu, H., Wang, Z., Jin, S., Hao, H.-J., Zheng, L., Zhou, B., Zhang, W., Lv, H., & Yuan, Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.105 · Cited by 50
Differential effects on p53-mediated cell cycle arrest vs. apoptosis by p90
Dai, C., Tang, Y., Jung, S. Y., Qin, J., Aaronson, S. A., & Gu, W. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110988108 · Cited by 50
The Menin Tumor Suppressor Protein Is Phosphorylated in Response to DNA Damage
Francis, J. M., Lin, W., Rozenblatt–Rosen, O., & Meyerson, M. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016119 · Cited by 50
Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death
Narayanan, K. B., Ali, M., Barclay, B. J., Cheng, Q. S., D'Abronzo, L. S., Dornetshuber-Fleiss, R., Ghosh, P., Guzman, M. J. G., Lee, T. J., Leung, P. S., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv032 · Cited by 50
ΔNp63α Silences a miRNA Program to Aberrantly Initiate a Wound-Healing Program That Promotes TGFβ-Induced Metastasis
Calleja, L. R., Jacques, C., Lamoureux, F., Baud’huin, M., Tellez-Gabriel, M., Quillard, T., Sahay, D., Perrot, P., Amiaud, J., Charrier, C., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2317 · Cited by 50
Evaluation of polylactic acid nanoparticles safety using Drosophila model
Legaz, S., Exposito, J., Lethias, C., Viginier, B., Terzian, C., & Verrier, B. (2016) · Nanotoxicology · doi:10.1080/17435390.2016.1181806 · Cited by 50
Roles of cancer/testis antigens (CTAs) in breast cancer
Li, Y., Li, J., Wang, Y., Zhang, Y., Chu, J., Sun, C., Fu, Z., Huang, Y., Zhang, H., Yuan, H., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.02.031 · Cited by 50
Small‐molecule stabilization of the p53 – 14‐3‐3 protein‐protein interaction
Doveston, R. G., Kuusk, A., Andrei, S. A., Leysen, S., Cao, Q., Castaldi, M. P., Hendricks, A., Brunsveld, L., Chen, H., Boyd, H., et al. (2017) · FEBS Letters · doi:10.1002/1873-3468.12723 · Cited by 50
Interrogation of MDM2 Phosphorylation in p53 Activation Using Native Chemical Ligation: The Functional Role of Ser17 Phosphorylation in MDM2 Reexamined
Zhan, C., Varney, K. M., Yuan, W., Zhao, L., & Lu, W. (2012) · Journal of the American Chemical Society · doi:10.1021/ja301255n · Cited by 50
IRES mediated translational regulation of p53 isoforms
Arandkar, S., Katoch, A., & Das, S. (2013) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1202 · Cited by 50
Gain-of-function mutant p53 activates small GTPase Rac1 through SUMOylation to promote tumor progressionPreprint
Yue, X., Zhang, C., Zhao, Y., Liu, J., Lin, A. W., Tan, V. M., Drake, J. M., Liu, L., Boateng, M. N., Li, J., et al. (2017) · Genes & Development · doi:10.1101/gad.301564.117 · Cited by 50
Discovery of phthalazino[1,2-b]-quinazolinone derivatives as multi-target HDAC inhibitors for the treatment of hepatocellular carcinoma via activating the p53 signal pathway
Liu, Q., Zhang, B., Wang, Y., Wang, X., & Gou, S. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.114058 · Cited by 49
HIF-2α mediates hypoxia-induced LIF expression in human colorectal cancer cells
Wu, L., Yu, H., Zhao, Y., Zhang, C., Wang, J., Yue, X., Yang, Q., & Hu, W. (2015) · Oncotarget · doi:10.18632/oncotarget.3017 · Cited by 49
Regulation of MDM2 Stability After DNA Damage
Li, J., & Kurokawa, M. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24994 · Cited by 49
A B56γ mutation in lung cancer disrupts the p53-dependent tumor-suppressor function of protein phosphatase 2A
Shouse, G., Nobumori, Y., & Liu, X. (2010) · Oncogene · doi:10.1038/onc.2010.161 · Cited by 49
Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences
Menéndez, D., Inga, A., & Resnick, M. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909129107 · Cited by 49
Mapping the p53 transcriptome universe using p53 natural polymorphs
Wang, B., Niu, D., Lam, T. H., Xiao, Z., & Ren, E. C. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.132 · Cited by 49
Jailbreak: Oncogene-induced senescence and its evasion
MDuff, F. K. E., & Turner, S. D. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.07.004 · Cited by 49
Reversal of the DNA-Binding-Induced Loop L1 Conformational Switch in an Engineered Human p53 Protein
Emamzadah, S., Tropia, L., Vincenti, I., Falquet, B., & Halazonetis, T. D. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.12.020 · Cited by 49
microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis
Zhang, C., Liu, J., Tan, C., Yue, X., Zhao, Y., Peng, J., Wang, X., Laddha, S. V., Chan, C. S., Zheng, S. S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7088 · Cited by 49
Long story short: p53 mediates innate immunity
Miciak, J. J., & Bunz, F. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.03.001 · Cited by 49
Human T-cell leukemia virus type-1-encoded protein HBZ represses p53 function by inhibiting the acetyltransferase activity of p300/CBP and HBO1
Wright, D. G., Marchal, C., Hoang, K., Ankney, J. A., Nguyen, S. T., Rushing, A. W., Polakowski, N. J., Miotto, B., & Lemasson, I. (2015) · Oncotarget · doi:10.18632/oncotarget.6424 · Cited by 49
RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma
Yu, S., Dai, J., Ma, M., Xu, T., Kong, Y., Cui, C., Chi, Z., Si, L., Tang, H., Yang, L., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1488-2 · Cited by 49
Hereditary myeloid malignancies
Rafei, H., & Dinardo, C. D. (2019) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2019.05.001 · Cited by 49
DNA Damaged Induced Cell Death in Oocytes
Gebel, J., Tuppi, M., Sänger, N., Schumacher, B., & Dötsch, V. (2020) · Molecules · doi:10.3390/molecules25235714 · Cited by 49
Emerging Roles of the Tumor Suppressor p53 in Metabolism
Yu, L., Wu, M. Y., Zhu, G., & Xu, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.762742 · Cited by 49
Involvement of stromal p53 in tumor-stroma interactions
Bar, J., Moskovits, N. B.-C., & Oren, M. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.11.006 · Cited by 49
p53: master of life, death, and the epigenomePreprint
Laptenko, O., & Prives, C. L. (2017) · Genes & Development · doi:10.1101/gad.302364.117 · Cited by 49
Self-citation
A Review: PI3K/AKT/mTOR Signaling Pathway and Its Regulated Eukaryotic Translation Initiation Factors May Be a Potential Therapeutic Target in Esophageal Squamous Cell Carcinoma
Huang, R., Dai, Q., Yang, R., Duan, Y., Zhao, Q., Haybaeck, J., & Yang, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.817916 · Cited by 48
p53 attenuates AKT signaling by modulating membrane phospholipid composition
Rueda-Rincón, N., Bloch, K. M., Derua, R., Vyas, R., Harms, A. C., Hankemeier, T., Khan, N. A., Dehairs, J., Bagadi, M., Binda, M. M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4067 · Cited by 48
Disruption of the 5S RNP–Mdm2 interaction significantly improves the erythroid defect in a mouse model for Diamond-Blackfan anemia
Jaako, P., Debnath, S., Olsson, K., Zhang, Y., Flygare, J., Lindström, M. S., Bryder, D., & Karlsson, S. (2015) · Leukemia · doi:10.1038/leu.2015.128 · Cited by 48
Periostin cooperates with mutant p53 to mediate invasion through the induction of STAT1 signaling in the esophageal tumor microenvironment
Wong, G. S., Lee, J., Park, Y.-Y., Klein–Szanto, A. J., Waldron, T. J., Cukierman, E., Herlyn, M., Gimotty, P. A., Nakagawa, H., & Rustgi, A. K. (2013) · Oncogenesis · doi:10.1038/oncsis.2013.17 · Cited by 48
Structure of full‐length p53 tumor suppressor probed by chemical cross‐linking and mass spectrometry
Arlt, C., Ihling, C. H., & Sinz, A. (2015) · PROTEOMICS · doi:10.1002/pmic.201400549 · Cited by 48
A RUNX2-Mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells
Shin, M. H., He, Y., Marrogi, E., Piperdi, S., Ren, L., Khanna, C., Gorlick, R. G., Liu, C., & Huang, J. L. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005884 · Cited by 48
Reverting p53 activation after recovery of cellular stress to resume with cell cycle progression
Lazo, P. A. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.02.005 · Cited by 48
Photobiomodulation leads to enhanced radiosensitivity through induction of apoptosis and autophagy in human cervical cancer cells
Djavid, G. E., Bigdeli, B., Goliaei, B., Nikoofar, A., & Hamblin, M. R. (2017) · Journal of Biophotonics · doi:10.1002/jbio.201700004 · Cited by 48
Reduction of the tumorigenic potential of human retinoblastoma cell lines byTFF1overexpression involves p53/caspase signaling and miR-18a regulation
Busch, M. A., Große-Kreul, J., Wirtz, J. J., Beier, M., Stephan, H., Royer‐Pokora, B., Metz, K. A., & Dünker, N. (2017) · International Journal of Cancer · doi:10.1002/ijc.30768 · Cited by 48
Hepatic p63 regulates steatosis via IKKβ/ER stress
Porteiro, B., Fondevila, M. F., Delgado, T. C., Iglesias, C., Imbernón, M., Iruzubieta, P., Crespo, J., Zabala‐Letona, A., Fernø, J., González‐Terán, B., et al. (2017) · Nature Communications · doi:10.1038/ncomms15111 · Cited by 48
Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot Study
Burke, M. J., Kostadinov, R. L., Sposto, R., Gore, L., Kelley, S. M., Rabik, C. A., Trepel, J. B., Lee, M.-J., Yuno, A., Lee, S., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1251 · Cited by 48
Stem cell quiescence and its clinical relevance
Luo, M., Li, J.-F., Yang, Q., Zhang, K., Wang, Z., Zheng, S. S., & Zhou, J. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i11.1307 · Cited by 48
p53 suppresses muscle differentiation at the myogenin step in response to genotoxic stress
Yang, Z., Brož, D. K., Noderer, W. L., Ferreira, J. P., Overton, K. W., Spencer, S. L., Meyer, T., Tapscott, S. J., Attardi, L. D., & Wang, C. L. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.189 · Cited by 48
De novo duplication of 17p13.1–p13.2 in a patient with intellectual disability and obesity
Kuroda, Y., Ohashi, I., Tominaga, M., Saito, T., Nagai, J., Ida, K., Naruto, T., Masuno, M., & Kurosawa, K. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36477 · Cited by 47
A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunity
Ory, B., & Ellisen, L. W. (2011) · Oncotarget · doi:10.18632/oncotarget.244 · Cited by 47
Therapeutic potential of p53 reactivation in prostate cancer: Strategies and opportunities
Kumari, S., Sharma, V., Tiwari, R., Maurya, J. P., Subudhi, B. B., & Senapati, D. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174807 · Cited by 47
Breathing new insights into the role of mutant p53 in lung cancer
Chen, T., Ashwood, L. M., Kondrashova, O., Strasser, A., Kelly, G. L., & Sutherland, K. D. (2024) · Oncogene · doi:10.1038/s41388-024-03219-6 · Cited by 49
LncRNAs: New Players in Gliomas, With Special Emphasis on the Interaction of lncRNAs With EZH2
Bian, E., Li, J., Xie, Y., Zong, G., Li, J., & Zhao, B. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24549 · Cited by 47
New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy
Guo, G., & Cui, Y. R. (2015) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-015-0053-5 · Cited by 47
TP53 PIN3 and PEX4 polymorphisms and infertility associated with endometriosis or with post-in vitro fertilization implantation failure
Paskulin, D. D., Cunha‐Filho, J. S., de Souza, C. A. B., Bortolini, M. C., Hainaut, P. L., & Ashton‐Prolla, P. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.116 · Cited by 47
Integral analysis of p53 and its value as prognostic factor in sporadic colon cancer
Sarasqueta, A. F., Forte, G. I., Corver, W. E., de Miranda, N. F. C. C., Ruano, D., van Eijk, R., Oosting, J., Tollenaar, R. A. �. �., van Wezel, T., & Morreau, H. M. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-277 · Cited by 47
MiR-192-Mediated Positive Feedback Loop Controls the Robustness of Stress-Induced p53 Oscillations in Breast Cancer Cells
Moore, R., Ooi, H. K., Kang, T., Bleris, L. G., & Ma, L. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004653 · Cited by 48
p53 and RAD9, the DNA Damage Response, and Regulation of Transcription Networks
Lieberman, H. B., Panigrahi, S. K., Hopkins, K. M., Wang, L., & Broustas, C. G. (2017) · Radiation Research · doi:10.1667/rr003cc.1 · Cited by 47
Myeloid p53 regulates macrophage polarization and venous thrombus resolution by inflammatory vascular remodeling in mice
Mukhopadhyay, S., Antalis, T., Nguyen, K. P., Hoofnagle, M. H., & Sarkar, R. (2017) · Blood · doi:10.1182/blood-2016-07-727180 · Cited by 47
The role of p38 MAPK pathway in p53 compromised state and telomere mediated DNA damage response
Roy, S., Roy, S., Rana, A., Akhter, Y., Hande, M. P., & Banerjee, B. (2018) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2018.05.018 · Cited by 48
Disruption of the Rbm38-eIF4E Complex with a Synthetic Peptide Pep8 Increases p53 Expression
Lucchesi, C. A., Zhang, J., Ma, B., Chen, M., & Chen, X. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-2209 · Cited by 47
p53 drives a transcriptional program that elicits a non-cell-autonomous response and alters cell state in vivo
Moyer, S. M., Wasylishen, A. R., Qi, Y., Fowlkes, N. W., Su, X., & Lozano, G. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008474117 · Cited by 47
Inhibition of the lncRNA MIAT prevents podocyte injury and mitotic catastrophe in diabetic nephropathy
Wang, Z., Chang, Y., Liu, Y., Liu, B., Zhen, J., Li, X., Lin, J., Yu, Q., Lv, Z., & Wang, R. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.03.001 · Cited by 47
Consequences of DJ-1 upregulation following p53 loss and cell transformation
Vasseur, S., Afzal, S., Tomasini, R., Guillaumond, F., Tardivel‐Lacombe, J., Mak, T. W., & Iovanna, J. (2011) · Oncogene · doi:10.1038/onc.2011.268 · Cited by 47
A low-dose hypersensitive keratinocyte loss in response to fractionated radiotherapy is associated with growth arrest and apoptosis
Turesson, I., Nyman, J., Qvarnström, F., Simonsson, M., Book, M., Hermansson, I., Sigurðardóttir, S., & Johansson, K.-A. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.10.007 · Cited by 47
ARF triggers senescence in Brca2-deficient cells by altering the spectrum of p53 transcriptional targets
Carlos, A. R., Escandell, J. M., Kotsantis, P., Suwaki, N., Bouwman, P., Badie, S., Folio, C., Benitez, J. J., Goméz-López, G., Pisano, D. G., et al. (2013) · Nature Communications · doi:10.1038/ncomms3697 · Cited by 47

Authors: Vousden, K. H., & Prives, C.
Affiliations: Cancer Research UK Scotland Institute (GB)
Columbia University (US)
Corresponding author: Vousden, Karen H.
Prives, Carol
ORCID: Vousden, Karen H.
Prives, Carol
Venue: Cell
Publisher: Elsevier BV
Published: 2009-05
Volume: 137
Issue: 3
Pages: 413-431
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/j.cell.2009.04.037
OpenAlex: W2133959309
Semantic Scholar: 018e8ed8c8694d45cfd9ffaf967368345fe22af6
Cited by: 3,163
References: 232
Citations by year: 2026: 128 · 2025: 154 · 2024: 127 · 2023: 168 · 2022: 149 · 2021: 166 · 2020: 175 · 2019: 149 · 2018: 171 · 2017: 191 · 2016: 228 · 2015: 202 · 2014: 258 · 2013: 263 · 2012: 228
FWCI: 17.35
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 1538 d)
doi.org/10.15223/policy-017 (stm-asf)
doi.org/10.15223/policy-037 (stm-asf)
doi.org/10.15223/policy-012 (stm-asf)
doi.org/10.15223/policy-029 (stm-asf)
doi.org/10.15223/policy-004 (stm-asf)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
Funders: Cancer Research UK
National Cancer Institute (R01CA077742, CA77742)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords: p53, tumor suppressor, transcriptional activation, p53 activators, p53 inhibitors, p53 regulation
MeSH terms: Animals, Cell Survival, Cell Transformation, Neoplastic, Gene Expression Regulation, Humans, Mutation, Stress, Physiological, Transcriptional Activation, Tumor Suppressor Protein p53, Apoptosis, Cell Proliferation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Blinded by the Light: The Growing Complexity of p53

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks